Cogent Biosciences develops targeted drugs for rare, genetically driven diseases, led by bezuclastinib for systemic mastocytosis and GIST. It last closed at $26.71 on Nov 20, down 3.70% on the day. The next earnings report for COGT is expected around Tue, Feb 16, 2027. For the quarter ended Sep 2026, COGT reported EPS of -$0.59. Over its last 8 reports the stock moved an average of 5.5% the session after earnings. Over the last 12 months COGT insiders bought $0 of stock on the open market and sold $383.9M, according to SEC Form 4 filings.
AI Auto Pilots
Is COGT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold COGT.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on COGTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
COGT · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 13% below its 20 day and 15% below its 50 day average. It is 31% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 36), near oversold. The nearest support is the 52 week low at $26.36, and the nearest resistance the Pivot at $27.06.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 5.9%/day
Key levels
$43.7352 week high+63.7%
$35.07200 day average+31.3%
$34.43100 day average+28.9%
$31.07Swing high (Oct 12)+16.3%
$30.7150 day average+15.0%
$30.0720 day average+12.6%
$27.49Pivot R1+2.9%
$27.06Pivot+1.3%
$26.71Last close
$26.3652 week low−1.3%
$26.36Swing low (Nov 17)−1.3%
$26.28Pivot S1−1.6%
Indicators
RSI (14)
35.65
Weak, oversold below 30
Neutral
MACD
-1.04
Below its signal line
Bearish
Stochastic
13.8
Near the bottom of its range
Oversold
ADX (14)
20.8
Weak trend
Williams %R
-95.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-138.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−15.6%
Change over 10 sessions
Bearish
ATR (14)
$1.56
Typical daily range, 5.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityLow, 12.0%/day
Key levels
$43.7352 week high+63.7%
$35.07200 day average+31.3%
$34.43100 day average+28.9%
$31.07Swing high (Oct 12)+16.3%
$30.7150 day average+15.0%
$30.0720 day average+12.6%
$27.49Pivot R1+2.9%
$27.06Pivot+1.3%
$26.71Last close
$26.3652 week low−1.3%
$26.36Swing low (Nov 17)−1.3%
$26.28Pivot S1−1.6%
Indicators
RSI (14)
34.32
Weak, oversold below 30
Neutral
MACD
-1.63
Below its signal line
Bearish
Stochastic
11.2
Near the bottom of its range
Oversold
ADX (14)
21.9
Weak trend
Williams %R
-97.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-127.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−20.0%
Change over 10 sessions
Bearish
ATR (14)
$3.20
Typical daily range, 12.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for COGT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how COGT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow COGT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for COGTHow many large options trades hit COGT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in COGT in the last 90 days.
From SEC Form 4 filings by COGT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether COGT is in one of them and how their past COGT trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Cogent Biosciences
Cogent Biosciences is a biotechnology company based in Waltham, Massachusetts, that develops drugs for diseases caused by specific genetic mutations. Its lead candidate, bezuclastinib, is being studied for systemic mastocytosis, a rare disease in which mast cells build up in the body, and for gastrointestinal stromal tumors, a cancer of the digestive tract. The company is also developing other targeted therapies, including inhibitors aimed at FGFR2/3 and ErbB2 mutations. Its intended patients are people with rare, genetically driven diseases.